Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today's Pharmaceutical Executive Daily, Johnson & Johnson, Processa Pharmaceuticals, and Relation strike new deals spanning cell therapy, BTK inhibition, and AI-driven target discovery, Inizio Engage launches Connected Insights to turn medical information interactions into strategic intelligence, and a commentary argues pharma companies need to manage direct-to-patient sales as a core commercial channel rather than a side program. Inizio Engage has launched Connected Insights , an expansion of its Global Medical Information platform designed to convert the more than one million scientific interactions it handles annually into strategic intelligence for pharmaceutical clients. The goal is to help Medical Affairs teams move beyond simply answering inquiries toward identifying trends and unmet needs across a product's full lifecycle. Thanks for listening to Pharmaceutical Executive Daily.